NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for erythropoietin


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Affymax and Takeda Announce Hematide(TM) Publication in the New England Journal of Medicine
2009 NOV 16 ... and reduced or eliminated the need for blood transfusion in most patients with erythropoietin-induced pure red cell aplasia (PRCA). The data were published in the 5th November 2009 ...
Subject: Affymax, Inc.
Price: $3.00
*
Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases AASLD Annual Meeting
2009 NOV 16 ... of the patients in the boceprevir arms and over a third of patients in the control arm. Erythropoietin (EPO) supplementation was allowed in the study at the discretion of the investigator ...
Subject: Schering-Plough Corporation
Price: $3.00
*
DaVita's 43 Abstracts Highlight Commitment to Quality Care at American Society of Nephrology's 2009 Renal Week
2009 NOV 16 ... the field of nephrology. Nocturnal hemodialysis improves hemoglobin sensitivity to Erythropoietin Therapy. The objective of this study was to determine if increased dialysis treatment ...
Subject: DaVita Inc.
Price: $3.00
*
Drugs to treat anemia in cancer patients linked to thromboembolism
2009 NOV 23 ... The anemia-reducing medications, known as erythropoiesis-stimulating agents (i.e., erythropoietin and darbopoietin) or ESAs, stimulate red blood cell production and are intended to ...
Subject: Columbia University Medical Center
Price: $3.00
*
Erythropoiesis-stimulating agents associated with higher risk of venous thromboembolism
2009 NOV 29 ... of the National Cancer Institute.Erythropoiesis-stimulating agents (i.e., erythropoietin and darbopoietin) stimulate red blood cell production and therefore were approved to ...
Subject: Journal of the National Cancer Institute
Price: $3.00
*
Findings in ischemia reported from C. Leconte and co-researchers
2009 NOV 9 ... that hypoxia-inducible factor-1 alpha expression as well as those of its target genes erythropoietin and adrenomedullin is increased by hypoxic postconditioning. Further studies with ...
Subject: Ischemia
Price: $3.00
*
Investigators at University of Frankfurt target stem cell research
2009 NOV 9 ... of EPCs in wild-type (WT) and Nox1 but not in Nox2 knockout (Nox2(y/-)) mice. As erythropoietin (EPO) is known to induce EPC mobilization, we focused on this hormone. EPO induced the ...
Subject: Stem Cell Research
Price: $3.00
*
New anemia study findings recently were reported by researchers at University of Glasgow
2009 NOV 23 ... causes iron overload by enhanced intestinal absorption. This study examined erythropoietin and intravenous (IV) iron requirements in hemodialysis (HD) patients with HFE ...
Subject: Anemia
Price: $3.00
*
New gastroenterology study findings have been reported by researchers at University of Bari
2009 NOV 9 ... New research, 'Mast cells and macrophages in duodenal mucosa of mice overexpressing erythropoietin,' is the subject of a report. "There is increasing evidence suggesting a wider ...
Subject: Gastroenterology
View Free
Daily News
Article
Reports summarize chemiluminescence study results from Tsinghua University
2009 NOV 16 ... to recent research published in the journal Electrophoresis, "The measurement of serum erythropoietin (EPO) is important for the detection of recombinant human EPO misuse in sports. In this ...
Subject: Chemiluminescence
Price: $3.00
*
Research from K. Vanpuyvelde and co-authors yields new data on chronic disease
2009 NOV 16 ... possible and if glomerular filtration rate is significantly decreased, treatment with erythropoietin should be considered. Most cases of myelodysplastic syndrome will benefit from ...
Subject: Chronic Disease
Price: $3.00
*
Research results from Y. Aso and co-authors update knowledge of anemia
2009 NOV 16 ... of diabetes, high-density lipoprotein (HDL) cholesterol, urinary albumin, and serum erythropoietin, whereas negative correlations were found with body mass index, triglyceride, eGFR, Hb, ...
Subject: Anemia
Price: $3.00
*
Scientists at Queen's University, Center for Infection target erythrocytosis genetics
2009 NOV 16 ... 'A new polycythaemia vera-associated SOCS3 SH2 mutant (SOCS3F136L) cannot regulate erythropoietin responses,' are discussed in a new report. According to recent research from Northern ...
Subject: Erythrocytosis Genetics
View Free
Daily News
Article
Studies from R. Nakamura et al further understanding of heart disease
2009 NOV 16 ... "Erythropoietin (EPO) has been shown to have effects beyond hematopoiesis, such as prevention of cardiac ...
Subject: Heart Disease
Price: $3.00
*
Studies from University of Vermont reveal new findings on apoptosis
2009 NOV 23 ... proliferation and diminished apoptosis. This correlated with increased expression of the erythropoietin receptor (Epor) and decreased expression of the death receptor Fas, respectively. ...
Subject: Apoptosis
Price: $3.00
*
Study results from C. Lonigro et al provide new insights into carcinoma
2009 NOV 9 ... studied and these studies have been fueled by evidence that hypoxia and, unexpectedly, erythropoietin (EPO), adversely affect the radiosensitivity of cells," scientists in Cuneo, Italy ...
Subject: Carcinoma
Price: $3.00
*
Study results from University of Palermo in the area of cerebral hemorrhage published
2009 NOV 16 ... for which no truly efficacious therapy has yet been identified. In preclinical studies, erythropoietin (EPO) and its long-lasting analog, darbepoetin alfa, have been demonstrated to be ...
Subject: Cerebral Hemorrhage
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login